Search

Your search keyword '"Blau, Igor Wolfgang"' showing total 11 results
Start Over Author "Blau, Igor Wolfgang" Publisher wiley
11 results on '"Blau, Igor Wolfgang"'

1. Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Nagler, Arnon, primary, Ngoya, Maud, additional, Galimard, Jacques‐Emmanuel, additional, Labopin, Myriam, additional, Blau, Igor Wolfgang, additional, Kröger, Nicolaus, additional, Gedde‐Dahl, Tobias, additional, Schroeder, Thomas, additional, Burns, David, additional, Salmenniemi, Urpu, additional, Rambaldi, Alessandro, additional, Choi, Goda, additional, Peffault de Latour, Régis, additional, Vydra, Jan, additional, Sengeloev, Henrik, additional, Eder, Matthias, additional, Mielke, Stephan, additional, Forcade, Edouard, additional, Kulagin, Alexander, additional, Ciceri, Fabio, additional, and Mohty, Mohamad, additional

Published
2024
Full Text
View/download PDF

2. Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core‐binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Ye, Yishan, primary, Labopin, Myriam, additional, Gérard, Socié, additional, Yakoub‐Agha, Ibrahim, additional, Blau, Igor Wolfgang, additional, Aljurf, Mahmoud, additional, Forcade, Edouard, additional, Gedde‐Dahl, Tobias, additional, Burns, David, additional, Vydra, Jan, additional, Halahleh, Khalid, additional, Hamladji, Rose‐Marie, additional, Bazarbachi, Ali, additional, Nagler, Arnon, additional, Brissot, Eolia, additional, Li, Lin, additional, Luo, Yi, additional, Zhao, Yanmin, additional, Ciceri, Fabio, additional, Huang, He, additional, Mohty, Mohamad, additional, and Gorin, Norbert Claude, additional

Published
2024
Full Text
View/download PDF

3. Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT

Author

McLornan, Donal P., primary, Gras, Luuk, additional, Martin, Ivonne, additional, Sirait, Tiarlan, additional, Schroeder, Thomas, additional, Blau, Igor Wolfgang, additional, Kuball, Jürgen, additional, Byrne, Jenny, additional, Collin, Matthew, additional, Stadler, Michael, additional, Desmier, Déborah, additional, Salmenniemi, Urpu, additional, Jindra, Pavel, additional, Mikhailova, Natalia, additional, Lenhoff, Stig, additional, Rifón, Jose, additional, Robin, Marie, additional, Rovira, Montserrat, additional, Veelken, Hendrik, additional, Sadowska‐Klasa, Alicja, additional, Zecca, Marco, additional, Hayden, Patrick J., additional, Czerw, Tomasz, additional, Hernández‐Boluda, Juan Carlos, additional, and Yakoub‐Agha, Ibrahim, additional

Published
2022
Full Text
View/download PDF

5. Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals

Author

Seidel, Danila, primary, Simon, Michaela, additional, Sprute, Rosanne, additional, Lubnow, Matthias, additional, Evert, Katja, additional, Speer, Claudius, additional, Seeßle, Jessica, additional, Khatamzas, Elham, additional, Merle, Uta, additional, Behrens, Christopher, additional, Blau, Igor Wolfgang, additional, Enghard, Philipp, additional, Haas, Christian S., additional, Steinmann, Joerg, additional, Kurzai, Oliver, additional, and Cornely, Oliver A., additional

Published
2021
Full Text
View/download PDF

11. Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT.

Author

Spyridonidis A, Labopin M, Savani B, Giebel S, Bug G, Schönland S, Kröger N, Stelljes M, Schroeder T, McDonald A, Blau IW, Bornhäuser M, Rovira M, Bethge W, Neubauer A, Ganser A, Bourhis JH, Edinger M, Lioure B, Wulf G, Schäfer-Eckart K, Arat M, Peric Z, Schmid C, Bazarbachi A, Ciceri F, Nagler A, and Mohty M

Abstract

In this registry-based study, we compared outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in adult patients with acute lymphoblastic leukemia (ALL) transplanted in first complete remission (CR-1), following conditioning with total body irradiation (TBI) at a standard 12-Gray or at a lower 8-Gray total dose. Patients received fludarabine (flu) as the sole chemotherapy complementing TBI. Eight-Gray TBI/flu was used in 494 patients and 12-Gray TBI/flu in 145 patients. Eighty-eight (23.1%) and 36 (29%) of the patients had Ph-negative B-ALL, 222 (58.3%) and 53 (42.7%) had Ph-positive B-ALL, 71 (18.6%) and 35 (28.2%) T-ALL, respectively ( P = 0.008). Patients treated with 8-Gray were older than ones received 12-Gray (median 55.7 versus 40.3 years, P < 0.0001) and were more frequently administered in vivo T-cell depletion (71% versus 40%, P <0.0001). In a multivariate model adjusted for age, type of ALL, and other prognostic factors, leukemia-free survival (primary endpoint) as well as relapse, nonrelapse mortality, overall survival, and GVHD-free, relapse-free survival were not influenced by the TBI dose. These results were confirmed when we focused on patients <55 years of age (median 47 years). Patients with Ph-positive ALL or T-ALL had significantly better survival outcomes than ones with Ph-negative B-ALL, mainly due to significantly fewer relapses. We conclude that 8-Gray TBI is sufficient for adult patients with ALL transplanted in CR-1 with no additional benefit of augmenting the conditioning intensity to 12-Gray., (Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results